Alvotech SA
General ticker "ALVO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.0B
Alvotech SA does not follow the US Stock Market performance with the rate: -17.5%.
Estimated limits based on current volatility of 1.8%: low 12.02$, high 12.45$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.82$, 15.32$]
- 2024-12-30 to 2025-12-30 estimated range: [4.78$, 13.02$]
Short-term ALVO quotes
Long-term ALVO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $36.77MM | $83.03MM | $91.43MM |
| Operating Expenses | $272.23MM | $429.47MM | $446.29MM |
| Operating Income | $-235.46MM | $-346.44MM | $-354.86MM |
| Non-Operating Income | $86.26MM | $-205.21MM | $-296.19MM |
| Interest Expense | $117.36MM | $188.42MM | $134.82MM |
| R&D Expense | $191.01MM | $180.62MM | $210.83MM |
| Income(Loss) | $-149.20MM | $-551.65MM | $-651.05MM |
| Taxes | $-47.69MM | $-38.07MM | $-99.32MM |
| Profit(Loss) | $-101.50MM | $-513.58MM | $-551.73MM |
| Stockholders Equity | $-135.61MM | $-564.42MM | $-932.49MM |
| Inventory | $39.06MM | $71.47MM | $74.43MM |
| Assets | $597.98MM | $828.44MM | $950.09MM |
| Operating Cash Flow | $-228.17MM | $-312.39MM | $-312.19MM |
| Capital expenditure | $40.63MM | $49.00MM | $46.47MM |
| Investing Cash Flow | $-40.63MM | $-63.54MM | $-46.34MM |
| Financing Cash Flow | $254.83MM | $424.91MM | $301.32MM |
| Earnings Per Share* | $-3.25 | $-2.60 | $-2.43 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.